KalGene

KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC

Published: 3Oct2016

KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed...

Back to top